{
    "code": "56031139",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56031139",
    "time": "2020-12-25 05:33:46",
    "許可證字號": "衛部醫器輸字第031139號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD5661",
    "有效日期": "112\/06\/07",
    "發證日期": "107\/06\/07",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05603113907",
    "中文品名": "亞培巨細胞病毒IgG抗體檢驗試劑組",
    "英文品名": "ABBOTT Alinity i CMV IgG Reagent Kit",
    "效能": "本產品以化學冷光微粒免疫分析法(Chemiluminescent Microparticle Immunoassay；CMIA)於Alinity i 分析儀上定性測試及半定量測定人類血清及血漿中對抗巨細胞病毒(Cytomegalovirus)之IgG抗體。",
    "醫器規格": "07P4222, 07P4232, 07P4201, 07P4210，以下空白。\r\n\r\n規格 (有效期間)及仿單標籤變更為：詳如中文仿單核定本。(原107年9月28日仿單標籤核定本正本收回作廢)。以下空白。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A1150校正品",
    "醫器主類別二": "A臨床化學及臨床毒理學",
    "醫器次類別二": "A1660品管材料(分析與非分析)",
    "醫器主類別三": "C免疫學及微生物學裝置",
    "醫器次類別三": "C3175巨細胞病毒血清試劑",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "製造廠名稱": "MIE0049100  ABBOTT IRELAND DIAGNOSTICS DIVISION",
            "製造廠廠址": "FINISKLIN BUSINESS PARK, SLIGO, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "1096816596變更核定仿單 (衛部輸031139)-109-10-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56031139&Seq=002&Type=9"
        },
        {
            "title": "1096816596變更核定仿單 (衛部輸031139)-109-10-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56031139&Seq=002&Type=8"
        }
    ]
}